Items where Funder is DIURNAL LTD.

N/A

Bacila, I., Freeman, N., Daniel, E. et al. (42 more authors) (2021) International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia - data from the I-CAH registry. European Journal of Endocrinology, 184 (4). pp. 553-563. ISSN 0804-4643

NONE

Karunasena, N., Margetson, D., Neal, G. et al. (2 more authors) (2017) Impact of food, alcohol and pH on modified-release hydrocortisone developed to treat congenital adrenal hyperplasia. European Journal of Endocrinology. ISSN 0804-4643

Jones, C.M., Mallappa, A., Reisch, N. et al. (10 more authors) (2016) Modified release and conventional glucocorticoids and diurnal androgen excretion in congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism. jc20162855. ISSN 0021-972X

PB-PG-1217-20007

Lawrence, N.R. orcid.org/0000-0002-7560-0268, Keevil, B.G., Elder, C. et al. (6 more authors) (2023) OR30-01: Waking salivary 11-hydroxyandrostenedione and cortisone as a novel non-invasive test for adrenal insufficiency. Journal of the Endocrine Society, 7 (Supplement_1). bvad114.351. ISSN 2472-1972

nan

Newell-Price, J., Huatan, H., Quirke, J. et al. (7 more authors) (2021) An oral lipidic native testosterone formulation that is absorbed independent of food. European Journal of Endocrinology, 185 (5). pp. 607-615. ISSN 0804-4643

Merke, D.P., Mallappa, A., Arlt, W. et al. (14 more authors) (2021) Modified-release hydrocortisone in congenital adrenal hyperplasia. The Journal of Clinical Endocrinology & Metabolism, 106 (5). e2063-e2077. ISSN 0021-972X

Merke, D.P., Mallappa, A., Arlt, W. et al. (14 more authors) (2021) Modified-release hydrocortisone in congenital adrenal hyperplasia. The Journal of Clinical Endocrinology & Metabolism, 106 (5). e2063-e2077. ISSN 0021-972X